Clearpoint Neuro, Inc.
|Number of Estimates|
Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.
Market Cap: 63.6 Million
Primary Exchange: NASDAQ
Shares Outstanding: 15.5 Million
Float: 11.4 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 70 trading days
From: 2020-02-13 To: 2020-05-22
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|